Advanced Pediatric Therapeutics (APT) is organized by pharmacy practice setting with major sections dedicated to the Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), Inpatient and Outpatient general practice, and Hematology/Oncology practice. APT is written for the advanced level practitioner with the assumption that the reader has a general/basic understanding of the disease state and common treatments. The primary focus is advanced management techniques, emerging research, and clinical controversies for each disease state. Each chapter incorporates a patient case and assessment questions.
As a book or in a convenient online/book package, PharmPrep goes where you go—on the subway, in the break room, to the coffeehouse. Or, just cozy up to the PharmPrep book from the comforts of home.
Waldman A.T. et al. Parent and medical professional willingness to enroll children in a hypothetical pediatric optic neuritis treatment trial. Frontiers in Neurology 2011;2(75): 1-6. 34. Chappuy H. et al. Parental consent in paediatric ...
Pediatric Pharmacotherapy focuses on the unique therapeutic needs of neonates, infants, children, and adolescents. Patients in these age groups offer challenges distinct from those of adult patients.
Schneider. Psoriasis is a debilitating disease characterized by recurrent exacerbations and remissions. It affects between 2% and 3% of the U.S. population, with a higher incidence in whites and an equal distribution between the sexes.
This exceptional text builds your knowledge of pharmacology by first providing an overview of pharmacologic principles and then teaching you how to apply those principles to clinical practice.
Phobias, panic disorders, school refusal, and anxiety. Autism and pervasive developmental disorders. Depression, mood disorders, and suicidal behavior. Alcohol and drug abuse. Eating disorders and obesity. PTSD.
Programs Affecting Safety and Innovation in Pediatric Therapies: Hearing Before the Subcommittee on Health of the Committee on Energy and...
Shapiro, G., L. Mendelson, M. Kraemer, M. Cruz-Rivera, and K. Walton-Bowen. 1998. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.
AAP also publishes Nelson's Pocket Book ofPediatric Antimicrobial Therapy, which is updated yearly.40 Both of these resources are limited to antimicrobial therapy. Other intermediary resources provide both adult and pediatric dosing.
The text includes numerous easy-to-scan tables and a popular "A to Z" drug formulary.